Correlation Between Sartorius Stedim and Vinci SA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and Vinci SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and Vinci SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sartorius Stedim Biotech and Vinci SA, you can compare the effects of market volatilities on Sartorius Stedim and Vinci SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of Vinci SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and Vinci SA.

Diversification Opportunities for Sartorius Stedim and Vinci SA

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Sartorius and Vinci is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and Vinci SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vinci SA and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with Vinci SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vinci SA has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and Vinci SA go up and down completely randomly.

Pair Corralation between Sartorius Stedim and Vinci SA

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to generate 3.42 times more return on investment than Vinci SA. However, Sartorius Stedim is 3.42 times more volatile than Vinci SA. It trades about 0.25 of its potential returns per unit of risk. Vinci SA is currently generating about 0.22 per unit of risk. If you would invest  18,763  in Sartorius Stedim Biotech on November 3, 2024 and sell it today you would earn a total of  3,717  from holding Sartorius Stedim Biotech or generate 19.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Sartorius Stedim Biotech  vs.  Vinci SA

 Performance 
       Timeline  
Sartorius Stedim Biotech 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Sartorius Stedim unveiled solid returns over the last few months and may actually be approaching a breakup point.
Vinci SA 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Vinci SA are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Vinci SA is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Sartorius Stedim and Vinci SA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sartorius Stedim and Vinci SA

The main advantage of trading using opposite Sartorius Stedim and Vinci SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, Vinci SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vinci SA will offset losses from the drop in Vinci SA's long position.
The idea behind Sartorius Stedim Biotech and Vinci SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities